POSTER SESSION V Wednesday, March 10, 2004   —  9:30 AM - 12:00 Noon EXHIBIT HALL B and C CYTOPATHOLOGY 46 Cervicovaginal Flora before and after SurePath (334) H Takei, B Ruiz - LSUHSC, New Orleans, LA 47 Utility of Human Papillomavirus (HPV) Testing in Normal Pap Smear (295) R Lakshminarayanan, LP Howell, J Gregg, S Hatcher, AM Afify - University of California, Davis, Sacramento, CA 48 Correlation between Atypical Squamous Cells of Undetermined Significance and HPV Tests: Before and after the 2001 Bethesda System (356) X Yang, PG Wasserman, M Sharaan, C Sugrue, D Halem, A Psellidas, N Morgenstern - Long Island Jewish Medical Center, New Hyde Park, NY 49 Reflex High Risk HPV DNA (Hybrid Capture 2) Testing of Bloody Thinprep Specimens with ASC-US Interpretation; Does Pretreatment with Acetic Acid Affect Test Performance? (265) J Feng, M Husain - Wayne State University, Detroit Medical Center, Detroit, MI 50 Utility of p16INK4a on Atypical Squamous Cells-Undetermined Significance (ASC-US): Does It Increase the Specificity of HPV Testing? (288) S Karikehalli, D Mandich, A Nasir, G Tsongalis, R Cartun, T Voytek - Hartford Hospital, Hartford, CT 51 The Weakly Positive Hybrid Capture Il Result for Human Papillomavirus: A Statistical and Comparative (PCR) Analysis (264) JM Federschneider, L Yuan, J Brodsky, G Breslin, A Cviko, R Betensky, CP Crum - Brigham and Women's Hospital, Boston, MA; Harvard School of Public Health, Boston, MA 52 Are Diagnostic Pap Tests Yielding More Abnormal Results Than Screening Pap Tests? (277) HE Gulbahce, K Kjeldahl, EB Stelow, G Oprea, K Savik, SE Pambuccian - University of Minnesota, Minneapolis, MN 53 Impact of the Bethesda 2001 ASC-US Re-Classification on the HPV Prevalence and Typing by PCR-Based Reflex Testing (276) HE Gulbahce, K Savik, S Setty, D McKeon, J Rohlader, EB Stelow, SE Pambuccian - University of Minnesota, Minneapolis, MN 54 Quantitative Analysis of the Hybrid Capture®II Human Papillomavirus Assay (306) SJ McCall, MB Datto, MJ Routbort - Duke University Medical Center, Durham, NC 55 Interobserver and Interlaboratory Reproducibility of Human Papillomavirus Detection by In Situ Hybridization (291) BJ Kerns, SJ Geyer - Ventana Medical Systems, Tucson, AZ; The Western Pennsylvania Hospital, Pittsburgh, PA 56 Reflex Testing for High-Risk HPV DNA Does Not Help in the Triage of Patients with Low-Grade Squamous Intraepithelial Lesion on Papanicolaou Smears (279) C Gupta, RD Danforth, Jr, S Suterwala - St. John Hospital and Medical Center, Detroit, MI 57 Frequency of Hybrid Capture 2 High Risk HPV DNA (HC2) Test Positivity of Residual Thin Prep Pap (TPP) Specimens in Routine Clinical Practice (282) M Husain, I Mielzynska-Lohnas, R Hallenberg - Detroit Medical Center/Wayne State University, Detroit, MI; Digene Corporation, Gaithersburg, MD 58 High Inter- and Intra-Observer Correlation in the Evaluation of Slide-Based High-Risk Human Papilloma Virus (HR-HPV) In-Situ Hybridization (ISH) (335) M Thomas, H You, P Mukunyadzi, LE De Las Casas, SJ Baker, S Korourian, PE Hermonat, M Gokden - University of Arkansas for Medical Sciences, Little Rock, AR 59 Efficacy of INFORM In-Situ Hybridization Assay in Predicting High-Grade Cervical Lesions (322) MN Qureshi, RD Rudelli, B Fitzpatrick, PJ Ringer - Lakewood Pathology Associates, Lakewood, NJ; Bayonne Medical Center, Bayonne, NJ 60 Cytomorphology of Extra-Mammary Paget's Disease of the Vulva in Pap Smears (274) M Gu,Z Ghafari, F Lin - University of California Irvine Medical Center, Orange, CA 61 "Negative but Limited by Absence of Squamocolumnar Junction Sampling ":An Option for Reporting a Negative Cervical Biopsy Following an Abnormal Pap Smear (329) D Shukla, J Henley, R Reyes, GA Herrerra, EA Turbat-Herrerra - LSU Health Sciences Center, Shreveport, LA 62 Clinical Significance of Cytologic Diagnosis of Atypical Glandular Cells of Undetermined Significance Favor Endometrial Origin: A Cytohistologic Correlation Study (326) RS Saad, H Takei, YL Liu, JC Kirkpatrick, JF Silverman, J Lipscomb, B Ruiz - Louisiana State University at New Orleans, New Orleans, LA; Allegheny General Hospital, Pittsburgh, PA 63 Clinical Significance of Endometrial Cells in Women ³ 40 Years of Ages in Pap Smear: Analysis of 817 Cases (354) C Xu, L Pisharodi - Women & Infants Hospital, Brown Medical School, Providence, RI; Rhode Island Hospital, Brwon Medical School, Providence, RI 64 Clinical Significance of the Presence of Cytologically Benign Endometrial Cells on Papanicolaou Smears in Women Age 40 and above: Experience at a Community Hospital (294) S Kurella, C Gupta, PF Mazzara - St.John Hospital and Medical Center, Detroit, MI 65 Benign-Appearing Endometrial Cells (BEMC) in Women ³40 Years Age: Did the 2001 Bethesda Revision Influence the Biopsy Rate and the Detection of EM Cancer? (255) BS Chang, T-J Browne, ES Cibas, DR Genest - Brigham and Women's Hospital and Harvard Medical School, Boston, MA